Alamar Biosciences (ALMR)
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection...
- Open
- 36.720
- High
- 38.280
- Low
- 34.010
- Prev. Close
- 36.570
- Volume
- 356.30K
- Turnover
- 12.65M
- Avg Price
- 35.507
- Bid/Ask Ratio
- 21.59%
- Amplitude
- 11.68%
- 52wk High
- 38.540
- Volume Ratio
- 2.11
- Turnover Ratio
- 0.99%
Alamar Biosciences Analyst Rating
View moreForecast & Rating
Aug 11, 2026Price forecast
$33.40-4.05%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 6 hours ago
Top 3 Health Care Stocks That May Implode In August
- rttnews · 11 hours ago
Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH
- Simplywall · 11 hours ago
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure
- benzinga_article · 1 day ago, 12:25 PM
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum
- benzinga_article · 1 day ago, 12:06 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · 1 day ago, 09:23 AM
Alamar Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results. Also, JP Morgan maintained its Overweight rating on the stock and raised its price target from $32 to $35.
